Logo image of THC

TENET HEALTHCARE CORP (THC) Stock Fundamental Analysis

USA - New York Stock Exchange - NYSE:THC - US88033G4073 - Common Stock

189.92 USD
+1.14 (+0.6%)
Last: 1/26/2026, 8:27:15 PM
189.92 USD
0 (0%)
After Hours: 1/26/2026, 8:27:15 PM
Fundamental Rating

6

We assign a fundamental rating of 6 out of 10 to THC. THC was compared to 103 industry peers in the Health Care Providers & Services industry. THC has an excellent profitability rating, but there are some minor concerns on its financial health. A decent growth rate in combination with a cheap valuation! Better keep an eye on THC. This makes THC very considerable for value investing!


Dividend Valuation Growth Profitability Health

9

1. Profitability

1.1 Basic Checks

  • THC had positive earnings in the past year.
  • In the past year THC had a positive cash flow from operations.
  • Each year in the past 5 years THC has been profitable.
  • Each year in the past 5 years THC had a positive operating cash flow.
THC Yearly Net Income VS EBIT VS OCF VS FCFTHC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B

1.2 Ratios

  • THC has a Return On Assets of 4.60%. This is in the better half of the industry: THC outperforms 73.79% of its industry peers.
  • THC's Return On Equity of 33.73% is amongst the best of the industry. THC outperforms 94.17% of its industry peers.
  • The Return On Invested Capital of THC (11.65%) is better than 85.44% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for THC is in line with the industry average of 9.21%.
  • The last Return On Invested Capital (11.65%) for THC is above the 3 year average (9.25%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 4.6%
ROE 33.73%
ROIC 11.65%
ROA(3y)4.91%
ROA(5y)3.9%
ROE(3y)50.24%
ROE(5y)332.92%
ROIC(3y)9.25%
ROIC(5y)8.01%
THC Yearly ROA, ROE, ROICTHC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500 1K

1.3 Margins

  • THC's Profit Margin of 6.49% is amongst the best of the industry. THC outperforms 84.47% of its industry peers.
  • In the last couple of years the Profit Margin of THC has grown nicely.
  • THC has a better Operating Margin (17.52%) than 96.12% of its industry peers.
  • In the last couple of years the Operating Margin of THC has grown nicely.
  • The Gross Margin of THC (82.26%) is better than 96.12% of its industry peers.
  • In the last couple of years the Gross Margin of THC has remained more or less at the same level.
Industry RankSector Rank
OM 17.52%
PM (TTM) 6.49%
GM 82.26%
OM growth 3Y10.99%
OM growth 5Y11.36%
PM growth 3Y48.9%
PM growth 5YN/A
GM growth 3Y-0.23%
GM growth 5Y-0.27%
THC Yearly Profit, Operating, Gross MarginsTHC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60 80

5

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so THC is still creating some value.
  • The number of shares outstanding for THC has been reduced compared to 1 year ago.
  • The number of shares outstanding for THC has been reduced compared to 5 years ago.
  • Compared to 1 year ago, THC has an improved debt to assets ratio.
THC Yearly Shares OutstandingTHC Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
THC Yearly Total Debt VS Total AssetsTHC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B 25B

2.2 Solvency

  • THC has an Altman-Z score of 1.84. This is not the best score and indicates that THC is in the grey zone with still only limited risk for bankruptcy at the moment.
  • With a Altman-Z score value of 1.84, THC perfoms like the industry average, outperforming 43.69% of the companies in the same industry.
  • THC has a debt to FCF ratio of 8.78. This is a slightly negative value and a sign of low solvency as THC would need 8.78 years to pay back of all of its debts.
  • Looking at the Debt to FCF ratio, with a value of 8.78, THC is in line with its industry, outperforming 50.49% of the companies in the same industry.
  • THC has a Debt/Equity ratio of 3.26. This is a high value indicating a heavy dependency on external financing.
  • THC's Debt to Equity ratio of 3.26 is on the low side compared to the rest of the industry. THC is outperformed by 74.76% of its industry peers.
Industry RankSector Rank
Debt/Equity 3.26
Debt/FCF 8.78
Altman-Z 1.84
ROIC/WACC1.34
WACC8.7%
THC Yearly LT Debt VS Equity VS FCFTHC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B 10B 15B

2.3 Liquidity

  • THC has a Current Ratio of 1.71. This is a normal value and indicates that THC is financially healthy and should not expect problems in meeting its short term obligations.
  • THC has a Current ratio of 1.71. This is in the better half of the industry: THC outperforms 67.96% of its industry peers.
  • A Quick Ratio of 1.64 indicates that THC should not have too much problems paying its short term obligations.
  • THC has a better Quick ratio (1.64) than 66.02% of its industry peers.
Industry RankSector Rank
Current Ratio 1.71
Quick Ratio 1.64
THC Yearly Current Assets VS Current LiabilitesTHC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

5

3. Growth

3.1 Past

  • THC shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 39.32%, which is quite impressive.
  • Measured over the past years, THC shows a very strong growth in Earnings Per Share. The EPS has been growing by 34.84% on average per year.
  • Looking at the last year, THC shows a decrease in Revenue. The Revenue has decreased by -0.56% in the last year.
  • The Revenue has been growing slightly by 2.26% on average over the past years.
EPS 1Y (TTM)39.32%
EPS 3Y16.22%
EPS 5Y34.84%
EPS Q2Q%26.28%
Revenue 1Y (TTM)-0.56%
Revenue growth 3Y1.98%
Revenue growth 5Y2.26%
Sales Q2Q%3.26%

3.2 Future

  • The Earnings Per Share is expected to grow by 13.65% on average over the next years. This is quite good.
  • THC is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.27% yearly.
EPS Next Y36.74%
EPS Next 2Y17.92%
EPS Next 3Y15.45%
EPS Next 5Y13.65%
Revenue Next Year2.31%
Revenue Next 2Y3.3%
Revenue Next 3Y3.83%
Revenue Next 5Y3.27%

3.3 Evolution

  • The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
THC Yearly Revenue VS EstimatesTHC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 5B 10B 15B 20B 25B
THC Yearly EPS VS EstimatesTHC Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 5 10 15 20 25

9

4. Valuation

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 12.24, THC is valued correctly.
  • Compared to the rest of the industry, the Price/Earnings ratio of THC indicates a rather cheap valuation: THC is cheaper than 84.47% of the companies listed in the same industry.
  • When comparing the Price/Earnings ratio of THC to the average of the S&P500 Index (27.25), we can say THC is valued rather cheaply.
  • THC is valuated reasonably with a Price/Forward Earnings ratio of 11.48.
  • Based on the Price/Forward Earnings ratio, THC is valued cheaply inside the industry as 87.38% of the companies are valued more expensively.
  • When comparing the Price/Forward Earnings ratio of THC to the average of the S&P500 Index (25.98), we can say THC is valued rather cheaply.
Industry RankSector Rank
PE 12.24
Fwd PE 11.48
THC Price Earnings VS Forward Price EarningsTHC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of THC indicates a rather cheap valuation: THC is cheaper than 90.29% of the companies listed in the same industry.
  • 83.50% of the companies in the same industry are more expensive than THC, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 11.11
EV/EBITDA 5.99
THC Per share dataTHC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 100 200

4.3 Compensation for Growth

  • THC's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • The excellent profitability rating of THC may justify a higher PE ratio.
  • THC's earnings are expected to grow with 15.45% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.33
PEG (5Y)0.35
EPS Next 2Y17.92%
EPS Next 3Y15.45%

0

5. Dividend

5.1 Amount

  • No dividends for THC!.
Industry RankSector Rank
Dividend Yield 0%

TENET HEALTHCARE CORP / THC FAQ

What is the ChartMill fundamental rating of TENET HEALTHCARE CORP (THC) stock?

ChartMill assigns a fundamental rating of 6 / 10 to THC.


What is the valuation status for THC stock?

ChartMill assigns a valuation rating of 9 / 10 to TENET HEALTHCARE CORP (THC). This can be considered as Undervalued.


Can you provide the profitability details for TENET HEALTHCARE CORP?

TENET HEALTHCARE CORP (THC) has a profitability rating of 9 / 10.


What is the valuation of TENET HEALTHCARE CORP based on its PE and PB ratios?

The Price/Earnings (PE) ratio for TENET HEALTHCARE CORP (THC) is 12.24 and the Price/Book (PB) ratio is 4.16.


Can you provide the expected EPS growth for THC stock?

The Earnings per Share (EPS) of TENET HEALTHCARE CORP (THC) is expected to grow by 36.74% in the next year.